This inventor holds 2 USPTO granted patents, plus 2 CIPO patents. Top assignees: National Institute of Health and Medical Research, Biophytis, Centre National De La Recherche Scientifique. Active years: 2012-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Paris, FR (2012)
- Cachan, FR (2019)
Company Filing History:


Years Active: 2012-2019
Title: Valerie Fontaine: Innovator in Ocular Disease Treatment
Introduction
Valerie Fontaine is a prominent inventor based in Cachan, France. She has made significant contributions to the field of ocular disease treatment, holding 2 patents that focus on innovative methods for addressing retinal degenerative diseases.
Latest Patents
One of her latest patents is titled "Use of 3-deoxyanthocyanidins for treating ocular diseases." This invention discloses a method for the treatment, prevention, and stabilization of age-related macular degeneration (ARMD), Stargardt disease, pigmentary retinopathy, and diabetic retinopathy. The method involves the application of a 3-deoxyanthocyanidin of a specific formula, ensuring that at least one of the substituents is a hydroxyl group. Another significant patent is "Trophic factor for the treatment of retinal degenerative diseases." This invention relates to methods and compositions for the detection and treatment of retinal degenerative diseases, particularly focusing on polypeptides that can protect against cone degeneration.
Career Highlights
Valerie Fontaine has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Biophytis. Her work in these institutions has been pivotal in advancing research and development in ocular health.
Collaborations
Throughout her career, Fontaine has collaborated with notable figures in the field, including Jose-Alain Sahel and Thierry Leveillard. These partnerships have further enriched her research and contributions to ocular disease treatment.
Conclusion
Valerie Fontaine's innovative work in the treatment of ocular diseases showcases her dedication to improving patient outcomes through scientific advancements. Her patents reflect a commitment to addressing critical health challenges in the field of ophthalmology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile